NImmune Biopharma ("NImmune"), a private late-stage precision inflammation and immunology ("I&I") biopharmaceutical company, will present first-ever preclinical and translational data demonstrating ...
Seven early career scientists across Canada are launching new cancer research programs thanks to $3.5 million in funding through the Terry Fox New Investigator Awards, announced today by the Terry Fox ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する